Joni Lamb, Founding Leader of Daystar, Dies at 65 Today
Joni Lamb, co-founder and longtime head of Daystar Television Network, has died at 65. The network confirmed the loss...
Which Credit Card Has Best Rewards Program
Compare credit cards to find the one with the best rewards program. Make an informed choice and maximize your benefits.
27,943 articlesBehind Grand Theft Auto: The CEO's $1.5B GTA VI Bet
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
Palantir Landed Next Billion: What It Means for Investors
A major government contract marks a turning point for Palantir. This analysis explains how the DHS deal could reshape...
Consumer Favorites Look Oversold as Markets Hold Today
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...
Rocket Lab Stock Soared: Still a Buy? A Closer Look
Rocket Lab has surged on new contracts and a growing backlog, yet investors wonder if the rally can last. This guide ...
Amazon Just Committed $200: The AI Stock Set for 2026
Amazon’s bold $200 billion capital expenditure plan signals a new era for AI infrastructure. This article breaks down...
Progressive's Underwriting Only Half: Rates Drive the Rest
Progressive is more than its ads. This article shows how underwriting profits interact with float income, and why ris...
Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Engineers, Not Business Operators: Loopring Shuts DEX
Loopring has halted trading on its decentralized exchange, citing outdated zkRollup tech and a strategic pivot toward...
Berkshire Hathaway Buying Back Signals Confidence in Cash
Berkshire Hathaway buying back its own stock marks a notable shift in how the company uses cash. Even a modest repurc...
Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status